Menu
6th CONGRESS OF THE SKIN INFLAMMATION & PSORIASIS INTERNATIONAL NETWORK

SCIENTIFIC PROGRAMME

SCHEDULE AT A GLANCE



Draft Preliminary Programme

Thursday, april 25

 

9:30-11:30 - Educational course on psoriasis

 

1. Genetics/pathogenesis 

2. Comorbidities 

3. Topical therapy 

4. Non-biologic systemic therapy 

5. Biologic systemic therapy

 

11:30-12:30    Sponsored Symposia

12.30-14.00    Welcome reception
 
14.00-14:10 – Congress Opening:

Fondation René Touraine Welcome and update on SPIN

 

14:10-16.00 – Plenary 1: Genetics and pathogenesis in psoriasis and atopic dermatitis

 

1. Genetics in psoriasis and atopic dermatitis 

2. New developments in immunopathogenesis of psoriasis

3. Genetics and immunopathogenesis of pustular variants of psoriasis

4. Autoimmunity vs autoinflammation in psoriasis

5. Pathogenesis in psoriasis and atopic dermatitis. Similarities and differences

 

16.30-18.00 – Focus Session 1: Epidemiology and registries

 

1. Registries in dermatology: strengths and learning points

2. Epidemiology of major inflammatory skin diseases anno 2019

3. Epidemiology of major inflammatory skin diseases in emerging countries

4. Comorbidity occurrence in major inflammatory skin diseases


Free communications 
  
16.30-18.00 – Focus Session 2: Advances in target-oriented therapy

 

1. Atopic dermatitis

2. Psoriasis 

3. Psoriatic arthritis 

4. Biomarkers in psoriasis and atopic dermatitis
 

Free communications 

 

16.30-18.00 – Patient Association’s Meeting

 

Friday, April 26  

 

08.30-10.00 – Focus Session 3: Autoinflammation and autoimmunity

 

1. Autoimmunity in psoriasis 

2. Life imaging of cutaneous immune-responses 

3. Microbiome in major inflammatory skin diseases

4. Autoinflammation and autoimmunity in psoriasis vs hidradenitis suppurativa 

 

Free communications 

 

08.30-10.00 – Focus Session 4: Beyond the skin

 

1. Psychological and psychiatric comorbidities in major inflammatory skin diseases

2. Hepatic and musculoskeletal disease in psoriasis 

3. Cardiovascular comorbidities in major inflammatory skin diseases

4. Auto-immune diseases in atopic dermatitis

 
Free communications  

 

10.30-12.30 – Plenary 2: Novelties in therapeutics

 

1. Anti TNF and small molecules in psoriasis 

2. Anti IL17 in psoriasis

3. Anti p40/anti p19 in psoriasis

4. New molecules in atopic dermatitis

5. Which drug for which patient ?

6. Latest trials on the effect of biotherapy on cardiovascular disease in psoriasis

 

12.30-14.00    Lunch break / Sponsored Symposia

 

14.00-15.30    Focus Session 5 - Topical treatments and physical modalities of treatment

 

1. Topical therapy in psoriasis and atopic dermatitis

2. UVB in psoriasis and atopic dermatitis

3. Innovative phototherapeutic approaches in psoriasis and atopic dermatitis

4. Physical treatment modalities in hidradenitis suppurativa

 

Free communications 

 

14.00-15.30 – Focus Session 6 – Advances and latest insights in non biologic systemic therapeutic agents in psoriasis and atopic dermatitis
 

1. Fumarates / Vitamin A Derivatives 

2. CsA / MMF /Azathioprine

3. MTX 

4. Apremilast and -inibs

 

Free communications  

 

 

15.30-18.00: SPIN Forum

 

1. Limitations on access to conventional/biologic therapy around the world
2. Screening and follow up for conventional/biologic therapy

3. Infections in patients under immunosuppressive drugs: learning from difference

Discussion

 

15.30-18.00:  How do I manage?
 

1. Pregnancy 

2. Childhood psoriasis 

3. Chronic hepatic disease

4. Chronic infections 

5. Nail psoriasis 

6. Recalcitrant atopic dermatitis 

 

 

Saturday, April 27

 

08.30-10.00 – Focus Session 7: Treatment goals/guidelines in major inflammatory skin diseases
 

1. Treatment goals in psoriasis 

2. Guideline variability across countries 

3. Drug survival 

4. Treatment outcomes and goals in atopic dermatitis 

 

Free communications           

 

08.30-10.00 – Focus Session 8: Individualized therapy in major inflammatory skin diseases

 

1. Treat to target 

2. Transitioning between biologics 

3. Combination therapy 

4. Therapeutic drug monitoring in biologics 

 

 Free communications 

 

10.30-12.30 – Plenary 3: Outcomes in psoriasis

 

1. Intro to value based healthcare, applied to a chronic disease model 

2. Patient relevant outcome measures in psoriasis (IDEOM) 

3. Measures to treat psoriasis beyond drugs

4. Can we justify the cost of a value based psoriasis approach? 

 

12.30-14.00    Lunch break / Sponsored Symposia

 

14.00-15.30 – Focus Session 9: Empowering HCPs in leadership and management

 

1. How to use resources effectively? 

2. How to organise multidisciplinary teams? 

3. How to deal with non-adherence in patients? 

4. Shared decision making in chronic illnesses 

 

14.00-15.30 – Focus Session 10: Special situations: children, pregnancy, old age, cancer patients in major inflammatory skin diseases

 

1. Pediatric patients with severe major inflammatory skin diseases 

2. Paradoxical reactions 

3. Scalp and genital psoriasis 

4. Old age/cancer patients

 

 Free communications

 

16.00-17.45 - Plenary 4: Medical need and Challenges in other Inflammatory Dermatoses
 
1. State of the art and future challenges in vitiligo
2. State of the art and future challenges in alopecia areata
3. State of the art and future challenges in hidradenitis suppurativa  

 

17.45-18.00 Closing remarks 
 

 

By continuing to browse this website, you accept cookies which are used to offer a personalized experience on our website, generate statistics and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Ok Read more